Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KCT0006873Phase 4Not yet recruiting
A Phase 4 trial of propofol, remimazolam in None, sponsored by Asan Medical Center. Planned start Feb 2022; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on KCT0006873.